Related Experiment Video
Updated: May 23, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Arthroprosthetic cobaltism and cardiomyopathy
Colin Machado1, Alan Appelbe, Robert Wood
1The Geelong Hospital, Geelong Cardiology Research Unit, P.O. Box: 281, Geelong, VIC 3220, Australia. colin_machado@yahoo.com
Severe cobalt poisoning from arthroplasty implants can cause serious health issues. Revision surgery improved symptoms, suggesting a link between cobaltism and implant wear.
Area of Science:
- Orthopedic Surgery
- Toxicology
- Cardiology
Background:
- Arthroplasty implants, particularly those containing cobalt, have been anecdotally linked to cobaltism.
- Previous cases reported neurological, endocrine, and cardiac symptoms, but causality remains unclear.
Observation:
- A 75-year-old male farmer presented with symptoms suggestive of cobalt cardiomyopathy.
- The patient had a history of arthroplasty, a potential source of cobalt exposure.
Findings:
- The patient exhibited severe cobalt poisoning.
- Revision of the hip arthroplasty led to significant symptomatic improvement, supporting the diagnosis of arthroprosthetic cobaltism.
Implications:
- This case strengthens the evidence linking arthroprosthetic cobaltism to systemic toxicity, including cardiomyopathy.
- Highlights the importance of considering implant-related toxicity in patients with unexplained multi-systemic symptoms.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction

